Tofacitinib 27241-0270
Product NDC
27241-0270- Manufacturer
- Ajanta Pharma Usa Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 3, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA219542
Need to source Tofacitinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tofacitinib Citrate | 11 mg/1 |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Packaging Options(1)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-270-30)